The use of stem cells for reconstructive or neuroprotective strategies can benefit from new advances in neuroimaging techniques to track grafted cells. In the present work, we analyze the potential of a neural stem cell (NSC) line, which stably expresses the glial cell line-derived neurotrophic factor (GDNF) and the firefly luciferase gene (GDNF/Luc-NSC), for cell therapy in a Huntington's disease mouse model. Our results show that detection of light photons is an effective method to quantify the proliferation rate and to characterize the migration pathways of transplanted NSCs. Intravenous administration of luciferine, the luciferase substract, into the grafted animals allowed the detection of implanted cells in real time by an optical neuroimaging methodology, overpassing the limits of serial histological analyses. We observed that transplanted GDNF/Luc-NSCs survive after grafting and expand more when transplanted in quinolinatelesioned nude mouse striata than when transplanted in nonlesioned mice. We also demonstrate that GDNF/Luc-NSCs prevent the degeneration of striatal neurons in the excitotoxic mouse model of Huntington's disease and reduce the amphetamine-induced rotational behavior in mice bearing unilateral lesions.
Introduction
Cell transplantation is one of the most promising approaches for the prevention and restoration of neural degeneration. Owing to their capacity to integrate in the host brain, stem cells releasing neuroprotective molecules have been proposed for ex vivo gene therapy. 1, 2 The use of genetically engineered neural stem cells (NSCs) delivering glial cell line-derived neurotrophic factor (GDNF) in an animal model of Parkinson's disease to reduce disease progression has been previously described. 3 GDNF has also stimulated great interest as a therapeutic candidate for Huntington's disease (HD) owing to its high expression in the striatum. 4 To exert its biological activities, GDNF signals through a twocomponent receptor complex consisting of the c-Ret and the GDNF family receptor-a. [5] [6] [7] These receptor subunits are expressed in the striatum and are upregulated after an excitotoxic lesion, suggesting an endogenous protective role after neuronal damage of this brain nucleus. 8 In fact, administration of exogenous GDNF, throughout the grafting of a fibroblast cell line genetically modified to constitutively release this trophic factor, protects striatal neuronal populations against quinolinate (QUIN). [9] [10] [11] However, the methodology used in these studies cannot be used for chronic pathologies because fibroblasts make tumors after brain transplants. 12 Thus, the use of NSCs for cell therapy in HD can constitute a powerful tool for releasing neurotrophic factors to protect striatal neurons in this movement disorder.
A common problem in cell therapy using NSCs is that cells cannot be tracked in vivo after grafting into the brain. Thus, in models of neurodegenerative disorders, tracking of stem cells over long periods of time is limited by the need to use histological procedures and multiple animals for each time point examined. In vivo, noninvasive imaging is an emerging methodology that allows the use of multiple luciferase reporters. Bioluminescent markers have been used successfully to noninvasively track local tumor growth and the development of metastasis in a variety of organs of living mice. [13] [14] [15] Owing to the absence of endogenous light-producing reactions in most mammal tissues, the use of bioluminescence markers for in vivo imaging is advantageous over the use of fluorescent reporters. 15 The luciferase from Photinus pyralis catalyzes the oxidation of luciferine, in the presence of ATP and oxygen, generating light photons and oxyluciferine. 13 The use of a high-sensitivity video camera to detect photons that traverse mouse tissues after luciferine administration has allowed repeated non-invasive imaging of luciferase-expressing tumors and metastases. 16 In the present work, we have adopted optical imaging procedures to monitor the fate of NSCs grafted into the brain of living mice during neuroprotective studies. To do this, we have generated the luciferase-expressing cell line GDNF/Luc-NSC using a retroviral vector for stable expression of transgenes. Our results demonstrate that in vivo optical neuroimaging allows tracking of lightproducing GDNF/Luc-NSCs grafted into QUINlesioned mouse brains. We also show that intrastriatal grafting of GDNF/Luc-NSCs protects striatal neurons against excitotoxicity, resulting in the prevention of locomotor impairment in a mouse model of HD.
Results
Light production by NSCs engineered to express enhanced green fluorescent protein (eGFP)-luciferase C17.2-neural stem cells (NSCs) were transduced using the peGFP-CMV/luc construct ( Figure 1a ) to obtain the eGFP and luciferase-expressing c17.2/Luc-NSC subline. A standard plot of luciferase activity measured in cell homogenates using a luminometer, relative light units (RLUs) vs number of cells, resulted in a linear graph (R 2 ¼ 0.987; Figure 1b) showing that light measurements can be used to estimate cell numbers.
The amount of light produced by a known number of c17.2/Luc-NSCs was also measured in tissue culture plates using a high-efficiency cooled charge-couple device (CCD) camera system (Figure 1c and d; ORCA-2BT; Hammamatsu Photonics, Hammamatsu City, Japan). Plots of light emission vs cell numbers were linear through the range of cells tested (R 2 ¼ 0.993; Figure 1c ). The slope of this linear regression, 8.732, indicated the number of RLU per cell. Assay sensitivity was defined as the number of cells required to generate a quantity of light equivalent to two times the standard deviation of background noise. 17 Our results show that the average of the standard deviations of photons (RLUs) detected from each of the predetermined numbers of cells is 75. Thus, the minimal differences in the number of cells that can be statistically detected is approximately 17 NSCs ((75 Â 2)/8.732).
With this instrument, the sensitivity for detection of small numbers of cells could be significantly increased by the aggregated reading of groups of CCD pixels (binning), resulting in a reduction of noise (binning 8 Â 8 (range 10-2000: R 2 ¼ 0.993); Figure 1d inset). However, binning reduces the linearity of intense signals, owing to the saturation of light detectors (range 10-10 000; R 2 ¼ 0.959; Figure 1d ). We also tested whether differentiation of c17.2/LucNSCs affects their light production capacity. EGFP expression was maintained after differentiation in the non-mitogenic N2 medium, during at least 14 days, the longest period tested (Figure 1e ). In addition, our results also demonstrated that differentiated cells maintain luciferase expression (Figure 1f ). No differences in light emission were detected between the same number of proliferating and differentiated c17.2/LucNSCs (Figure 1f ).
Quantification and tracking of brain-engrafted NSCs by optical neuroimaging C17.2/Luc-NSCs grafted into the brains of nude mice could be easily detected in vivo using the imaging system ( Figure 2 ). To establish the sensitivity range, nude mice were bilaterally inoculated with 10 000 and 5000 c17.2/Luc-NSCs. Light emission by the grafted NSCs was imaged between minutes 6 and 10 following either intraperitoneal (i.p.) or intravenous (i.v.) inoculation of D-luciferine (100 mg/kg). Intravenous inoculation of luciferine increased light detection sensitivity by approximately 220-240% when compared to the Optical neuroimaging for neuroprotective studies JR Pineda et al detection sensitivity after i.p. injection of luciferine ( Figure 2 ). These findings show that i.v. injected luciferine reaches the brain region efficiently via the vascular system. Interestingly, c17.2/Luc-NSCs were detected from the second day after transplantation (Figure 3b ), but no light emission was observed in any condition 1 day after the implantation of NSCs into the brain (Figure 3a ). Histological analysis of the NSCgrafted brains showed that at this short time post grafting, cells were still at the inoculation sites ( Figure  3c ). However, at the second day, c17.2/Luc-NSCs are more dispersed and integrated in the brain tissue ( Figure  3d ). Thus, a plausible explanation for the lack of light production the first day post inoculation could be an inefficient supply of luciferine to the cells, owing to the absence of an established vascular system. In fact, the coinjection of c17.2/Luc-NSCs with luciferine allowed the detection of light when imaged just after grafting (data not shown), demonstrating that when luciferine reaches the transplanted cells, light emission can be easily detected.
To determine whether in vivo optical neuroimaging could be used to quantify low numbers of brainengrafted cells and their proliferation rate, known numbers, ranging from 100 to 10 000, of c17.2/Luc-NSCs were intrastriatally injected in nude mice. The animals were imaged at 1 week post-engraftment, when grafted NSCs can easily be detected by optical neuroimage (Figure 3e ). Plot of light production vs the number of transplanted c17.2/Luc-NSCs were linear through the tested range of cell numbers (R 2 ¼ 0.986; Figure 3f ). The slope of the resulting linear regression plot, a measure of the amount of light/(cell Â min), indicated that the c17.2/Luc-NSCs transplanted into the striatum-generated 9.97 RLU/min/grafted cell. The minimal number of transplanted c17.2/Luc-NSCs that we could detect was 500 cells per striatum at the highest sensitivity possible (8 Â 8 binning; Figure 3e and f).
To better determine the correlation between the number of c17.2/Luc-NSCs present in transplanted mouse brains and the RLU recorded, at 6 weeks postengraftment, mice grafted with different numbers of c17.2/Luc-NSCs were imaged, to measure light emission, and in the same day they were processed for histology (see Material and methods for details). We performed stereological counting of eGFP-positive c17.2/Luc-NSCs in the brain sections from animals grafted with different number of c17.2/Luc-NSCs. These experiments, which allowed us to compare the RLU with the exact number of cells in each mice, demonstrated a lineal correlation between RLU/min and the number of eGFP-positive cells (R 2 ¼ 0.958; Figure 3g ). The slope of the linear plot indicated that each eGFP-positive c17.2/Luc-NSC produced 7.42 RLU/min, a number consistent, considering the experimental constraints, with that found for cells 1 week post grafting.
Repetitive imaging of the same animal allowed determination of the proliferation rate for implanted c17.2/Luc-NSCs (Figure 3h ), based on the changes in light emission. Light from transplanted cells detected by optical neuroimaging of the same animal 1 week and 6 weeks post implantation (Figure 3h ) showed an increase in intensity that varied depending on the number of transplanted cells. We observed that mice engrafted with a lower number of c17.2/Luc-NSCs had a larger increase in light emission than mice engrafted with a larger number of cells (data not shown). These increase in light emission also correlated with a time-dependent increase in stereologically counted eGFP-positive c17.2/LucNSCs. As with the case for light production, the increase in eGFP counts was also larger for mice grafted with the lower than for those grafted with the larger numbers of cells (number of population doublings vs number of grafted cells: 9.94, 500 grafted cells; 9.25, 1000 grafted cells; 8.57, 2000 grafted cells; 6.46, 10 000 grafted cells). The proliferation rate of c17.2/Luc-NSCs after grafting was similar to that detected for the parental cell line c17.2-NSC (data not shown), suggesting that the expression of eGFP and luciferase does not affect the proliferation of NSCs after grafting.
Light detection may be affected by the amount of tissue intervening between the cells and the CCD camera. It seems not to be a problem in small animals like mice, although one should expect noticeable impairments in larger animals.
Migratory behavior of implanted cells
To test the possibility that implanted c17.2/Luc-NSCs would migrate and could be detected using optical neuroimaging, we implanted 5000 c17.2/Luc-NSCs in the rostral migratory stream (Figure 4a ), a well-characterized migratory pathway for NSCs of the subventricular zone. 18 Light emission images taken 1 week after grafting showed the cells localized at the grafting site ( Figure 4b ). However, 6 weeks post grafting, the light signal at the injected sites was reduced and a new light spot was detected in the olfactory bulb region (Figure 4c ), suggesting that grafted cells migrated from the original implantation site (Figure 4b ). Histological analysis of the light-producing brain area showed eGFP-positive c17.2/ Luc-NSCs (Figure 4d ) in the granular and glomerular cell layers of the olfactory bulb, the natural migration target for NSCs from the subventricular zone. 18 Some eGFP- Optical neuroimaging for neuroprotective studies JR Pineda et al positive cells were also detected throughout the corpus callosum (data not shown) corresponding to low levels of light detected in the forebrain by optical imaging (Figure 4c ).
Optical neuroimaging to monitor NSCs in neuroprotective studies
GDNF-expressing c17.2-NSCs (GDNF-NSC) and mocktransfected c17.2 (MT-NSC) described by Akerud et al., 3 were transduced with the peGFP-CMV/luc construct (GDNF/Luc-NSC and MT/Luc-NSC, respectively). Both GDNF/Luc-NSCs and MT/Luc-NSCs produced similar amounts of light/cell, and in linear proportion to cell number (data not shown). Expression of eGFP and luciferase had no effect on the capacity of GDNF-NSCs for GDNF expression. Our analysis showed that while the parental cell line (GDNF-NSC) secreted 19.973.77 ng of GDNF per 10 6 cells in 1 day, the GDNF/Luc-NSC cell line produced a very similar quantity, 18.4272.1 ng of GDNF per 10 6 cells in 1 day (Figure 5a ). The expression of eGFP and luciferase did not alter the morphology or the fate of the GDNF-NSC lines, and all characteristic phenotypes, including neurons and glia, were detected in differentiated GDNF/ Luc-NSCs (Figure 5b ). 
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To analyze the effects of NSCs in a QUIN model of HD, we first studied the effect of this N-methyl-Daspartate (NMDA)-receptor agonist on cultures of c17.2/ Luc-NSCs. QUIN treatment did not affect the viability and/or proliferation of c17.2/Luc-NSCs (Figure 5c ). However, we observed differences in the behavior of c17.2/Luc-NSC implanted in QUIN-lesioned and nonlesioned striata. Mice were bilaterally grafted (n ¼ 4-5 per group) with GDNF/Luc-NSCs or MT/Luc-NSCs. The following day, left striata received an injection of QUIN and during the following 14 days the mice were monitored periodically by optical neuroimaging. The analysis revealed that light emission from both GDNF/ Luc-NSCs and MT/Luc-NSCs was 59-69% higher in lesioned striata than in sham-treated (phosphatebuffered saline; PBS) ones (Figure 6a and b) . This result was also confirmed by histological analysis, which showed higher numbers of eGFP-positive NSCs in QUIN-lesioned mice than in PBS-treated mice (Figure  6c and d; QUIN-mice, 272729% with respect to shamtreated mice, 100710%). In addition, the graft volume, measured 15 days after grafting, in QUIN-lesioned mice, was a 19570.1% larger than in PBS-injected mice (10076%). The analysis of cell proliferation at the second day post-engraftment showed that QUIN-lesioned mice had a proliferation rate of a 15757330% with respect to PBS-injected mice (100717%). However, no differences in proliferation capacity were detected by optical neuroimaging between GDNF/Luc-NSCs and MT/LucNSCs (data not shown). Taken together, these findings demonstrate that NSCs have a higher proliferation rate when transplanted into lesioned striata than in shamoperated controls. This effect cannot be attributed to a direct action of QUIN on NSCs, as we did not detect any effect of QUIN on NSCs in culture (Figure 5c ).
We next tested whether QUIN lesion affected the fate of transplanted NSCs or the production of GDNF. We have previously described that GDNF-NSCs predominantly colocalize with CNPase staining, a marker for oligodendrocytes. 3 We now observe that while most of the GDNF/Luc-NSCs were also positive for CNPase 
Intrastriatal grafting of GDNF/Luc-NSCs prevents behavior impairment induced by QUIN lesions
To determine whether the neuronal protective effects of GDNF/Luc-NSCs correlated with functional improvements, we assayed the grafted mice for amphetaminestimulated circling behavior. Control mice that received a unilateral striatal QUIN lesion but no cell grafting showed asymmetric behavior after the i.p. administration of the dopaminergic indirect agonist. The number of net rotations was partially reduced by previous grafting of GDNF/Luc-NSCs (Figure 8 ). However, the protective effect was not observed in animals transplanted with MT/Luc-NSCs (Figure 8 ). The reduction in the number of net rotations in animals grafted with GDNF/Luc-NSCs was of 54.3+8.2% relative to non-grafted QUIN-lesioned mice and of 52.8+13.3% relative to MT/Luc-NSCs-grafted mice. Thus, our findings demonstrated that GDNF/Luc-NSCs partially prevent the behavioral deficits induced in the excitotoxic lesion model of HD.
Discussion
Studies using NSC transplants to remediate neurodegenerative disorders could benefit from the development of neuroimaging procedures to track cells implanted in the brain of living animal models. In the current work, we show that NSCs expressing luciferase implanted into the brain of nude mice can be tracked, quantified and characterized in vivo by neuroimaging of optical photons generated by the luciferase-luciferine reaction, without the need for skull and skin withdrawal. This technique allows the study of the neuroprotective effects of GDNFoverexpressing NSCs in the excitotoxic model of HD. Optical neuroimaging for neuroprotective studies JR Pineda et al GDNF protects striatal projection neurons and improves behavioral abnormalities. Optical luminescent neuroimaging is a sensitive approach for the detection of implanted cells, which benefits from the absence of competing endogenous light-producing reactions in the brain. This method allowed us to detect a minimum number of about 500 intrastriatal grafted NSCs, a number slightly higher than that detected by other non-invasive techniques such as magnetic resonance imaging (MRI). Although Stroh et al. 19 reported the detection of approximately 10 magnetically labeled cells using MRI, this neuroimaging technique does not allow the quantification of transplanted cells or the evaluation of their proliferation capacity. 19 The advantage of luciferase labeling is that the number of light photons produced by the labeled cells can be used to determine their number. Thus, in the current experiments, the number of photons emitted by luciferase-expressing NSCs correlated linearly with the number of cells counted in vitro. In vivo, a similar linear correlation was shown between the amount of light recorded by the imaging system and the number of brain-engrafted NSCs stably expressing luciferase. Our findings also demonstrate a linear correlation between cell number estimates, calculated from light recorded by optical neuroimaging, and the results of independent stereological cell counts in the same animal.
Implanted NSCs showed migratory behavior, homing to the granular and glomerular cell layers of the olfactory bulb when they were grafted in the rostral migratory stream, the natural migratory pathway for NSCs of the subventricular zone. Therefore, optical bioluminescent imaging can be used as a quantitative method for tracking luciferase-expressing NSCs implanted in the brains of live animals.
Genetic markers also have additional advantages over other methods used for tracking stem cells in vivo such as magnetic particles for MRI. Exogenous non-replicating markers are diluted in the proliferating cell population and, what is more problematic; the label released by dead cells can be taken up again by neighboring cells when the tagged transplanted ones die. Keeping with this view, we have previously observed 3 H-thymidinepositive astrocytes in brains transplanted with dead prelabeled cells, suggesting that endogenous brain cells acquire non-biodegradable markers (Canals, Akerud and Arenas, unpublished results). Importantly, while we observed that the expression of luciferase and eGFP genes does not alter the differentiation of NSCs in vitro and in vivo, it has been reported that differentiation of mesenchymal stem cells is altered after magnetic labeling. 20, 21 We next analyzed the cell behavior of the GDNF/LucNSCs when transplanted in a mouse excitotoxic model of Optical neuroimaging for neuroprotective studies JR Pineda et al HD. 22 We show that expression of eGFP and luciferase genes did not affect the levels of GDNF expression, which were maintained after the cells had survived in the brain for at least a 15-day period. Similarly, the expression of eGFP and luciferase or the repetitive administration of luciferine and light emission analysis during the life of the mice did not modify the fate determination of these NSCs. In addition, in vivo optical imaging showed that NSCs transplanted in QUINlesioned striata proliferate more than cells transplanted into intact striata, a result corroborated by histological analysis of eGFP-expressing cells and in agreement with previously published data. 23 These proliferative responses is not a direct effect of QUIN on NSCs and suggest that the implanted cells are well integrated in brain tissue and respond to endogenous signals.
We finally demonstrated that transplanted GDNF/ Luc-NSCs protect striatal neurons from excitotoxicity and partially reverse behavioral impairments in this severe mouse model of HD. We have previously described that GDNF and other trophic factors are good neuroprotective factors for HD. 5 As we show here and in previous work, 3 implanted GDNF/Luc-NSCs disperse widely in the striatum where, under the control of a mammalian promoter, express and administer GDNF for long periods of time. These results indicate that this strategy provides a suitable vehicle for delivery of neuroprotective factors, determinant in the treatment of this neurodegenerative disorder and useful as a tool for development of therapeutic approaches.
In conclusion, we find that optical neuroimaging can be advantageously used to sensitively detect and quantify cells implanted in the brain of live animals, allowing studies of their proliferation and homing behavior. What is more, we were able to show that NSCs-mediated release of GDNF protects striatal neurons and may constitute a useful therapeutic strategy in the treatment of HD.
Materials and methods
Cell culture and transduction C17.2-NSCs and GDNFexpressing c17.2-NSCs (GDNF-NSC) or mock-transfected c17.2-NSCs (MT-NSC) were cultured as described previously by Akerud et al. 3 Cells in the proliferation state were transduced, as described Baum et al., 24 with the retroviral construct peGFPCMVluc, for expression of eGFP and Photinus pyralis luciferase (Luc). Positive eGFP-expressing cells, the top 2%, were purified by cell sorting using a fluorescenceactivated cell sorting (FACS; MoFlo Flow Cytometer; Cytomation Inc., Fort Collins, CO, USA). The resulting cell pools, c17.2/Luc-NSC, GDNF/Luc-NSC and MT/ Luc-NSC, respectively, were expanded in Dulbecco's modified Eagle's medium (DMEM; Gibco-BRL, Renfrewshire, Scotland, UK) supplemented with 10% fetal calf serum (Gibco-BRL), 5% horse serum (Gibco-BRL), and 2 mM glutamine (Sigma-Aldrich, Steinheim, Germany) in standard conditions (371C, 5% CO 2 ). Cells were split (1:10) when they reached 80-90% of confluence.
To differentiate NSC lines in vitro, cells were grown for 1 week in N2-supplemented DMEM-F12 (1:1 mixture of F12 and DMEM containing: 10 ng/ml insulin, 100 mg/ml transferine, 100 mM putrescine, 20 nM progesterone, 30 nM selenium, 6 mg/ml glucose and 1 mg/ml bovine serum albumin (BSA)), in poly-D-lysine (Sigma-Aldrich)-coated dishes.
In order to analyze the proliferation rate in culture after QUIN administration, c17.2/Luc-NSCs were treated with different doses of QUIN (0, 5, 10, 20 or 40 mM) and 48 h later we perform an extended pulse of 5-bromodeoxyuridine (BrdU; Roche Diagnostics GmbH, Mannheim, Germany) as described elsewhere. 25 The mitotic marker was added to the culture at 3 mg/ml during a 24 h period and the cultures were fixed with 4% paraformaldehyde. After three washes with PBS, cells were treated with HCl 2 M for 30 min, followed by four washes in PBS. The cell cultures were then processed for immunocytochemistry for detection of BrdU using an anti-BrdU antibody (1:50; Dako A/S, Glostrup, Germany). Immunocytochemistries were counterstained with 4 0 ,6-diamidino-2-phenylindole (DAPI; SigmaAldrich) to visualize and count the total number of cells.
Animal procedures
Nude mice (Swiss nu/nu; 25-35 g) were from Charles River Laboratories (Les Oncins, France). Nude mice were used because previous work had shown better cell survival in these animals, 3 because they do not produce immunological rejection. The animals were maintained with unlimited access to food and water, at constant temperature (19-221C) and humidity (40-50%) on a 12:12 h light/dark cycle. All animal-related procedures were performed in accordance with the National Institute of Health Guide Lines for the care and use of laboratory animals, with the approval of the animal care committee of the University of Barcelona and the Generalitat de Catalunya.
For cell grafting, animals were anesthetized with pentobarbital (50 mg/kg i.p.), placed in a Stoelting stereotaxic apparatus (Wood Dale, IL) with the incisor bar at À3 mm. GDNF/Luc-NSC and MT/Luc-NSC cells in the actively growing phase were washed twice with Hank's Balanced Salt Solution, trypsinized and dissociated with a fire-polished Pasteur pipette, pelleted and then resuspended in DMEM at the indicated concentration. GDNF/Luc-NSC or MT/Luc-NSC were grafted in four locations at the following coordinates (in millimeters); anteroposterior (AP), +0.8 and +0.33; lateral (L), 71.8 and 72 from bregma and dorsoventral (DV), À2.55 and À2.75 from dura. Cell grafting was performed unilaterally or bilaterally as indicated. Cell viability was 495% at the end of the transplantation session, as determined by the trypan blue dye exclusion. At 1 day after the grafting procedure, mice were striatally lesioned with 2 Â 0.5 ml of 10 mg/ml QUIN (20 nmols; SigmaAldrich) in the left hemisphere at the following coordinates; AP, +0.8 and +0.33; L, +1.8 and +2 from bregma and DV, À2.65 from dura.
To follow the proliferation of grafted NSCs, we treated three bilateral grafted mice with BrdU (50 mg/kg) 1 day following QUIN or PBS injection. After 24 h, mice were deeply anaesthetized in a CO 2 chamber and transcardially perfused with a 4% paraformaldehyde solution in 0.1 M sodium phosphate, pH 7.2. Brain tissue was post-fixed for 2 h in the same solution, cryoprotected with 10% sucrose in PBS and frozen in dry ice-cooled isopentane. Sections were treated with 2 M HCl Optical neuroimaging for neuroprotective studies JR Pineda et al and processed for immunohistochemistry as describe Bosch et al. 25 Three animals were grafted in the rostral migratory stream (AP, +1.5 and L, +0.7 from bregma; and DV À2.3 from dura) in order to examine the migration potential of NSCs.
Enzyme-linked immunosorbent assay (ELISA)
To study GDNF secretion, cells were cultured in 24-well plates for 24 h in differentiation medium. The medium was collected and the cells in each well were counted. GDNF contents was determined in 50 ml duplicates of cell culture supernatants, after a 1:1 dilution with block or sample buffer, using the Emax ImmunoAssay system (Promega, Madison, WI, USA), according to the manufacturer's instructions. Duplicates of serial dilutions containing recombinant GDNF (0-1000 pg/ml) were also analyzed in order to generate a standard curve. Results were expressed as ng of GDNF per 10 6 cells per day.
In vitro luciferase assay
Cell lysates were prepared by performing a one freezethaw cycle in Reporter Lysis Buffer (RLB; Promega). To generate light vs cell number standard curves and calculate the linear regression coefficient, luciferaseexpressing NSCs were diluted serially from 10 to 10 000 cells and analyzed for light generation (n ¼ 3). Luciferase activity in cells was measured by chemiluminescence, using the standard luciferase assay kit (Promega). Light production was measured using a Turner Designs luminometer model TD 20/20, after the addition of 100 ml of luciferase assay reagent (Promega) to 20 ml of cell lysate. Light detector measurements were expressed in RLU. Non-invasive in vivo optical imaging was performed using a high-sensitive CCD camera (ORCA-2BT Imaging System; Hammamatsu Photonics). To correlate the recorded light intensities with the numbers of cells, standard curves were generated by measuring light produced by 100 to 10 000 cell serial dilutions in 24-well plates (n ¼ 6). Images were captured, using the ORCA-2BT system.
In vivo optical neuroimaging
In vivo optical neuroimaging of intrastriatally grafted nude mice was performed as described previously by El Hilali et al. 16 Mice were anesthetized with a mixture of droperidol (Roche, Basel, Switzerland) 6 mg/kg and midazolam (Rovi S.A., Madrid, Spain) 12 mg/kg. For imaging, the mice were i.p. or i.v. inoculated with 150 ml of an aqueous solution of D-luciferine (100 mg/kg; Promega) and placed at 247 mm distance from the camera objective in the detection chamber of a highefficiency ORCA-2BT Imaging System, Hammamatsu Photonics) provided with a C4742-98-LWG-MOD camera and a 512 Â 512 pixel, charge-couple device (CCD) cooled at À801C. Images were acquired during 1 min period, routinely starting 4 min after luciferine administration. Light measurements were expressed as RLUs. Immediately after image acquisition, while the animal remained in the same position, another image of the animal was obtained using an ambient light. As indicated in some experiments, to increase detection sensitivity, the reading noise of the recorded signal was reduced by an 8 Â 8 binning of the camera CCD. Quantification and analysis of photons recorded in images was carried out using the WASABI image analysis software (Hammamatsu Photonics). The Orca system records absolute light events detected by the CCD in the image memory. The gray scale/color values displayed by the WASABI image processing software are chosen to best represent the range of values in the image memory. This necessity arises from the fact that computer monitors cannot display accurately the complete range of values that the image memory can store. However, the scale is always the same within the experiment. Thus, a given color in an image always represents the same range of light intensity recorded by the Orca system CCD output.
In order to establish the correlation between the number of transplanted cells and the emitted light, a standard curve was generated by grafting predetermined numbers of c17.2/Luc-NSCs in the brains of mice (n ¼ 4). Data are represented as the number of RLUs vs number of grafted cells. The slope of the linear regression curve is the number of in vivo RLU/min per transplanted cell.
Immunostaning
C17.2/Luc-NSC, GDNF/Luc-NSC or MT/Luc-NSC were induced to differentiate in vitro on glass cover slips using non-mitotic medium, N 2 . After 7 days of culture, cells were fixed with 4% paraformaldehyde in PBS for 45 min at room temperature. Immunostaining was performed as described elsewhere. 25 In brief, samples were incubated for 30 min with PBS containing 0.3% Triton X-100 and 30% normal horse serum (NHS; Gibco-BRL). Thereafter, the cover slips were incubated overnight at 41C in PBS containing 0.3% Triton X-100 and 5% NHS, and the corresponding primary antibodies. The following antibodies and dilutions were used: anti-GFAP (glial fibrillary acidic protein; 1:400; Sigma-Aldrich), anti-Tuj1 (1:250; Sigma-Aldrich), anti-CNPase (1:250, Chemicon, Temecula, CA, USA). Following three washes with PBS, the cultures were incubated for 2 h at room temperature with the appropriate biotinylated secondary antibody. The signal was developed using the avidin-biotin complex procedure (ABC; Pierce, Rockford, IL, USA), and finally visualized with 3,3 0 -diaminobenzidine. For immunohistochemistry, at day 15 post implantation, nude mice were deeply anaesthetized in a CO 2 chamber and transcardially perfused with a 4% paraformaldehyde solution in 0.1 M sodium phosphate, pH 7.2. Brain tissue was post-fixed for 2 h in the same solution, cryoprotected with 10% sucrose in PBS and frozen in dry ice-cooled isopentane. Serial coronal cryostat sections (30 mm thick) through the whole striatum were collected as free-floating in PBS and processed for immunohistochemistry as described elsewhere. 25 After three rinses with PBS, slices were incubated with NH 4 Cl 50 mM to reduce background autofluorescence. Tissue was permeabilized with PBS-T buffer (PBS containing 0.3% Triton X-100, 1.5% NHS and 1% BSA) at room temperature for 1 h. After washing in PBS, the slices were incubated overnight at 41C with the corresponding primary antibodies and dilutions: anti-GFAP (1:400; Sigma-Aldrich), anti-NeuN (1:100; Chemicon), anti-CNPase (1:250, Chemicon), anti-GDNF (1:20, R&D Systems, Inc., Minneapolis, MN, USA), which were combined with the anti-GFP (1:400; Abcam Ltd, Cambridge, UK) to detect the transplanted cells. Samples were then incubated for 2 h at room temperature with 
Stereological cell counting
All cell counts were performed using a blind-coded procedure. In cell cultures, DAPI-positive nuclei were counted as the total number of cells. Total cell number and BrdU-positive neurons were counted after fluorescent immunocytochemistry in four independent cultures. Several fields comprising 5% of the cover slip surface were randomly chosen using the Computer Assisted Stereology Toolbox (CAST) software (Olympus Danmark A/S, Ballerup, Denmark), and the numbers of positive cells were counted for each staining. In order to correlate light recorded by optical neuroimaging with the number of transplanted cells in the same animal, eGFP-expressing cells were counted using a stereological method. Light emission was first recorded using the Orca system as described above. At 2 h after imaging, the animals were processed for immunohistochemistry, also as described, and eGFPpositive cells were counted (n ¼ 8). Only cells showing a clear eGFP-positive cytoplasm were counted as positive. Unbiased stereological counts were obtained from the entire graft using the CAST software (Olympus Danmark A/S) as described previously by Canals et al. 26 The amount of light recorded from each animal, expressed as RLU/min, was plotted vs the number of eGFP-positive NSCs counted. To analyze the graft volume, the area including the eGFP-positive NSCs in each section was outlined and the volume was calculated by multiplying the sum of all the outlined areas (square millimeters) by the distance between successive sections (0.3 mm).
BrdU-positive cells were counted in the selected graft area using the stereological dissector (CAST, Olympus Danmark A/S). Results were expressed as the average of three mice per condition tested and normalized to the mean of sham-grafted mice.
To count the spared striatal neurons after QUIN lesion in grafted and non-grafted mice, we performed a double immunohistochemistry for NeuN and eGFP (n ¼ 6). NeuN-positive cells in overall striatum area were counted as described previously by Canals et al. 26 The few cells that were simultaneously positive for NeuN and eGFP were excluded from the cell counts. Stereological counts were obtained from the entire neostriatum using the CAST software (Olympus Danmark A/S). The dissector counting method was employed to analyze coronal sections spaced 98 mm apart. The counted frames were randomly sampled.
Behavioral measurements
Turning behavioral testing was performed 14 days after striatal QUIN-induced lesions in mice grafted unilaterally with GDNF/Luc-NSC or MT/Luc-NSC and in nongrafted animals. Groups of mice grafted with GDNF/ Luc-NSCs or MT/Luc-NSCs, and non-grafted mice were mixed and data were recorded using a blind procedure. Mice were injected i.p. with amphetamine (2.5 mg/kg) to induce turning behavior as described previously by Akerud et al.
